Anterix Inc. (ATEX) Balance Sheet

The balance sheet expansion is primarily attributable to a surge in cash and equity, not productive assets. PPE net has steadily declined, suggesting minimal investment in physical infrastructure. This implies that the company's growth is financial rather than operational, with the spectrum asset not yet translating into tangible rate base.

The decline in PPE suggests limited capital expenditure on physical assets, with the spectrum license likely carried at historical cost or not on the balance sheet. This creates a disconnect between the company's strategic asset and its reported book value, making traditional rate base analysis inapplicable. Investors should monitor any future capitalization of spectrum costs or impairments.

The company's leverage is negligible, with total debt of only $4.1M against $285.8M equity. This provides ample financial flexibility but also suggests that the company is not utilizing debt to fund operations, possibly due to the speculative nature of its revenue. The equity increase likely stems from capital raises or one-time gains, not retained earnings, as operating losses persist.

The substantial equity increase is not supported by operational performance, as the company has reported negative operating income in most quarters. The 2026Q2 net income spike of $53.5M, likely a one-time gain, contributed to equity but is not repeatable. This raises questions about the quality of equity and the sustainability of the balance sheet strength.

The liquidity position is robust, with cash and equivalents covering current liabilities comfortably. However, the cash build appears to be from financing activities rather than operations, as operating cash flow has been negative in several quarters. This suggests the company is reliant on external capital to fund its cash burn, and liquidity could deteriorate if capital markets tighten.